ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "MRI"

  • Abstract Number: 1190 • 2014 ACR/ARHP Annual Meeting

    Osteoarthritis-like Changes Are Present in the Tibia and Femur 1 Year Following ACL Reconstruction

    Valentina Pedoia1, Drew A. Lansdown2, Musa Zaid3, Charles McCulloch4, C. Benjamin Ma2 and Xiaojuan Li5, 1Department of Radiology & Biomedical Imaging, Musculoskeletal Quantitative Imaging Research, UCSF, San Francisco, CA, 2Department of Orthopedic Surgery, UCSF, San Francisco, CA, 3Musculoskeletal Quantitative Imaging Research, UCSF, San Francisco, CA, 4Department of Epidemiology and Biostatistics, San Francisco, CA, 5Department of Radiology and Biomedical Imaging, Musculoskeletal Quantitative Imaging Research, UCSF, San Francisco, CA

     Background/Purpose Statistical Shape Modeling (SSM) is a promising tool that has the ability to characterize complex shapes in a brief feature vector. The application of…
  • Abstract Number: 855 • 2014 ACR/ARHP Annual Meeting

    Active and Structural Lesions on MRI of the Sacroiliac Joints Predict Major Clinical Responses in Patients with Non-Radiographic Axial Spondyloarthritis Treated with Etanercept

    Walter P. Maksymowych1, S Wichuk1, H Jones2, A Szumski3, L Marshall4, J Bukowski5 and RG Lambert6, 1Department of Medicine, University of Alberta, Edmonton, AB, Canada, 2Inflammation & Immunology, Pfizer Inc., Collegeville, PA, 3Specialty Care, Pfizer Inc., Collegeville, PA, 4Inflammation Immunology Disease Group, Pfizer Inc., Collegeville, PA, 5Pfizer Inc., Collegeville, PA, 6Radiology, University of Alberta, Edmonton, AB, Canada

    Background/Purpose: Previous studies evaluating predictors of major clinical response in patients with non-radiographic axial SpA (nr-axSpA) receiving treatment with anti-TNF agents have been limited by…
  • Abstract Number: 2563 • 2014 ACR/ARHP Annual Meeting

    The Distribution of Inflammatory Lesions in the Anterior and Posterior Structures of the Spine in Patients with Active Ankylosing Spondylitis and the Effect of TNF-α-Blockade

    Xenofon Baraliakos1, Kay-Geert A. Hermann2, Stephen Xu3, Benjamin Hsu3 and Jürgen Braun1, 1Rheumazentrum Ruhrgebiet, Herne, Germany, 2Radiology, Charité Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany, 3Janssen Research & Development, LLC., Spring House, PA

    Background/Purpose Magnetic resonance imaging (MRI) is a key tool for the assessment of inflammatory lesions used for diagnosis and the monitoring of treatment effects in…
  • Abstract Number: 1187 • 2014 ACR/ARHP Annual Meeting

    Scoring of Spinal Lesions Compatible with Axial Spondyloarthritis on MRI in Clinical Practice By Local Radiologist or Rheumatologist in Desir; Comparison with Central Reading

    Manouk de Hooge1, Jean-Baptiste Pialat2, Monique Reijnierse1, Désirée van der Heijde1, Pascal Claudepierre3, Alain Saraux4, Maxime Dougados5 and Antoine Feydy5, 1Leiden University Medical Center, Leiden, Netherlands, 2Hôpital Edouard Herriot, Lyon, France, 3Henri Mondor Teaching Hospital, Creteil, France, 4CHU Brest and EA 2216, UBO, Brest, France, 5Descartes University, Cochin Hospital, Paris, France

    Background/Purpose: In clinical practice radiologists and rheumatologists assess whether lesions compatible with axial SpondyloArthritis (axSpA) are present on spinal MRI. The objective was to compare…
  • Abstract Number: 595 • 2014 ACR/ARHP Annual Meeting

    Radiographic Sacroiliitis Progression in an Early Axial Spondyloarthritis Cohort

    Concepcion Castillo-Gallego1, Jesus Sanz2, Carmen Martin-Hervas3, Mireia Moreno4, Victoria Navarro-Compán5, Diana Peiteado1, Jorge Gratacos-Masmitja6, Eugenio De Miguel7 and Emilio Martín-Mola1, 1Rheumatology, Hospital La Paz - IdiPaz, Madrid, Spain, 2Rheumatology, Hospital Puerta de Hierro Majadahonda, Madrid, Spain, 3Radiology, Hospital Universitario La Paz, Madrid, Spain, 4Rheumatology, University Hospital Parc Taulí, Sabadell, Spain, 5Rheumatology, Rheumatologist, Madrid, Spain, 6Parc Tauli, S/N, Hospital Parc Tauli, Sabadell, Spain, 7Department of Rheumatology, Hospital Universitario La Paz, Madrid, Spain

    Background/Purpose: The current concept of axial Spondyloarhtritis (axSpA) considers non-radiographic axSpA (nr-axSpA) and Ankylosing Spondylitis (AS) as two stages of one disease. There are limited…
  • Abstract Number: 2490 • 2014 ACR/ARHP Annual Meeting

    Assessment of Structural Benefits of SC Abatacept Using MRI in Patients with RA Who Have Failed 1 or 2 TNFs and Correlated with Clinical Outcomes As Measured By DAS28(ESR)

    Norman B. Gaylis1, Steven Needell2 and Joanne Sagliani3, 1Arthritis & Rheumatic Disease Specialties, Aventura, FL, 2Boca Radiology, Boca Raton, FL, 3Research, Arthritis & Rheumatic Disease Specialties, Aventura, FL

    Background/Purpose: Previous studies1-2 suggest the structural benefit of IV abatacept in patients with RA who have previously failed MTX, TNF therapy or both. Objectives:This study…
  • Abstract Number: 1186 • 2014 ACR/ARHP Annual Meeting

    Prevalence of MRI Spinal Lesions Typical for Axial Spondyloarthritis in Patients with Inflammatory Back Pain

    Manouk de Hooge1, Jean-Baptiste Pialat2, Antoine Feydy3, Monique Reijnierse1, Pascal Claudepierre4, Alain Saraux5, Maxime Dougados3 and Désirée van der Heijde1, 1Leiden University Medical Center, Leiden, Netherlands, 2Hôpital Edouard Herriot, Lyon, France, 3Descartes University, Cochin Hospital, Paris, France, 4Henri Mondor Teaching Hospital, Creteil, France, 5CHU de la Cavale Blanche, Brest Cedex, France

    Background/Purpose: A cut-off value of ³3 inflammatory lesions was suggested by the ASAS/OMERACT group, as positive MRI of the spine (MRI-spine). Moreover, fatty lesions on…
  • Abstract Number: 594 • 2014 ACR/ARHP Annual Meeting

    Do Bone Marrow Edema Lesions in the Sacroiliac Joint Change into Fatty Lesions over a 1-Year Period in Patients with Axial Spondyloarthritis or Possible Spondyloarthritis

    Pauline Bakker1, Rosaline van den Berg2, Manouk de Hooge1, Floris van Gaalen2, Monique Reijnierse1, T.W.J. Huizinga1 and Désirée van der Heijde3, 1Leiden University Medical Center, Leiden, Netherlands, 2Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 3Rheumatology, Diakonhjemmet Hospital, Oslo, Norway

    Background/Purpose: Bone marrow edema (BME) lesions in the sacroiliac joint (SIJ) may change into fatty lesions over time. Fatty lesions are regarded as the earliest…
  • Abstract Number: 2214 • 2014 ACR/ARHP Annual Meeting

    Power Doppler Ultrasonography for Detection of Abnormal Fascial Vascularity: A Potential Early Diagnostic Tool in Fasciitis of Dermatomyositis

    Ken Yoshida1, Makiko Nishioka2, Satoshi Matsushima2, Kensuke Joh3, Yosuke Oto1, Yoshiga Masayuki1, Kazuhiro Otani1, Haruyash Ito1, Kenichiro Hirai1, Kazuhiro Furuya1, Taro Ukichi1, Kentaro Noda1, Isamu Kingetsu1 and Daitaro Kurosaka1, 1Internal Medicine, Jikei University School of Medicine, Tokyo, Japan, 2Rheumatology, Jikei University School of Medicine, Tokyo, Japan, 3Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan

    Background/Purpose We have previously demonstrated that fasciitis is a common lesion of dermatomyositis (DM) detectable early after disease onset by en bloc biopsy combined with…
  • Abstract Number: 1183 • 2014 ACR/ARHP Annual Meeting

    Validation of the Omeract Psoriatic Arthritis Magnetic Resonance Imaging Score for the Hand and Foot in a Randomized Placebo-Controlled Trial

    Daniel Malm1, P. Bird2, Frédérique Gandjbakhch3, Philip J. Mease4, Pernille Bøyesen5, Mikkel Østergaard6, Charles G. Peterfy7 and Philip G. Conaghan8, 1Center for Rheumatology and Spinal Diseases, Copenhagen University Hospital at Glostrup, Glostrup, Denmark, 2Combined Rheumatology Practice, Sydney, Australia, 3Service de Rhumatologie, Groupe Hospitalier Pitie Salpetriere, Paris, France, 4Swedish Medical Center and University of Washington, Seattle, WA, 5Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 6Center for Rheumatology and Spine Diseases, Glostrup Hospital, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Glostrup Hospital, Glostrup, Denmark, 7Spire Sciences LLC, Boca Raton, FL, 8Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Chapel Allerton Hospital, Leeds, United Kingdom

    Background/Purpose The joint involvement in psoriatic arthritis (PsA) is heterogeneous, and inflammation is seen in both axial and peripheral joints, including the small joints of…
  • Abstract Number: 540 • 2014 ACR/ARHP Annual Meeting

    Two Years Sacroiliac Radiographic Progression Rate and Influence of Baseline Markers of Inflammation in Recent Onset Spondyloarthritis

    Maxime Dougados1, Christophe Demattei2, Rosaline van den Berg3, Viet Vo Hoang4, Fabrice Thévenin5, Monique Reijnierse6, Damien Loeuille7, Antoine Feydy8, Pascal Claudepierre9 and Désirée van der Heijde10, 1INSERM (U1153): Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, Paris, France., Paris, France, 2Service BESPIM, CHU, Nimes, France, 3Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 4Department of radiology, Lyon, France, 5Radiology B, Paris Descartes University, Côchin Hospital, APHP, Paris, France, 6Radiology, Leiden University Medical Center, Leiden, Netherlands, 7Rhumatology, CHU Nancy, Vandoeuvre Les Nancy, France, 8Paris Descartes University, Radiology B department, Cochin Hospital, paris, France, 9Rheumatology, Paris-Est University; LIC EA4393; APHP, Henri Mondor Hospital, Creteil, France, 10LUMC, Leiden, Netherlands

    Background/Purpose: According to the ASAS axial spondyloarthritis (SpA) criteria, patients suffering from inflammatory back pain (IBP) can be recognized as suffering from axial SpA even…
  • Abstract Number: 2132 • 2014 ACR/ARHP Annual Meeting

    What Is Associated with X- Ray Progression at 5 Years in Rheumatoid Arthritis (RA) Patients in Low Disease Activity?

    Violaine Foltz1, Lisa Biale2, Frederique Gandjbakhch1, Laure Gossec1, Pierre Bourgeois1, Benjamin Granger3 and Bruno Fautrel1, 1Rheumatology, UPMC Paris 06 University, GRC 08, Paris France and Pitié Salpétrière Hospital Paris France, Paris, France, 2Rheumatology, Instruction des Armées Begin hospital, Saint-mande, France, 3Departement de santé publique, information medicale et biostatistiques, unite biotstatistiques, UPMC Paris 06 University, GRC 08, Paris France and Pitié Salpétrière Hospital Paris France, Paris, France

    Background/Purpose Persistent inflammation on Power Doppler (PD) by ultrasound (US) was associated with relapse and structural progression after one year of follow up in a…
  • Abstract Number: 1170 • 2014 ACR/ARHP Annual Meeting

    Neurological Complications during Anti-TNF Therapy: A Prospective Imaging and Electrophysiological Study

    Evripidis Kaltsonoudis1, Anastasia Zikou2, Paraskevi V. Voulgari3, Spyridon Konitsiotis4, Maria Argyropoulou5 and Alexandros A. Drosos6, 1Rheumatology Clinic, Department of Internal Medicine, Rheumatologist, Ioannina, Greece, 2Department of Clinical Imaging and Radiology, Medical School, University of Ioannina, Ioannina, Greece, Lecturer of Radiology, Ioannina, Greece, 3Rheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, 45110, Associate Professor of Rheumatology, Ioannina, Greece, 4Department of Neurology, Associate Professor of Neurology, Ioannina, Greece, 5Department of Clinical Imaging, Professor of Radiology, Ioannina, Greece, 6Rheumatology Clinic, Department of Internal Medicine, University of Ioannina, Ioannina, Greece

    Background/Purpose The aim was to investigate the frequency of neurological adverse events in patients with rheumatoid arthritis (RA) and spondylarthropathies (SpA) treated with tumor necrosis…
  • Abstract Number: 513 • 2014 ACR/ARHP Annual Meeting

    Analysis of Shoulder Joint Destruction in Rheumatoid Arthritis Patients Treated with Biologics

    Yukio Yonemoto, Koichi Okamura, Tetsuya Kaneko, Chisa Okura and Kenji Takagishi, Department of Orthopaedic Surgery, Gunma University Graduate School of Medicine, Maebashi, Japan

    Background/Purpose The assessment of joint destruction in rheumatoid arthritis (RA) patients being treated with biologics is normally mainly carried out for small joints. There are…
  • Abstract Number: 2142 • 2014 ACR/ARHP Annual Meeting

    Sensitivity and Precision of Automated Osteophyte Volumetric Measurement in Knee Osteoarthritis over Four Years

    Michael Hakky1, Charles Ratzlaff2, Mohamed Jarraya3, Ali Guermazi4 and Jeffrey Duryea5, 1Radiology, Lahey Clinic, Burlington, MA, 2Harvard Medical School / Brigham and Women's Hospital, Boston, MA, 3Boston University School of Medicine, Boston, MA, 4Radiology, Boston University School of Medicine, Boston, MA, 5Dept of Radiology, Brigham & Women, Boston, MA

    Background/Purpose: Osteophyte formation and evolution is a hallmark of knee OA, and their radiographic identification and progression is fundamental in clinical practice, observational research and…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology